Using multiplex immunoassay, researchers found that AD patients had significantly higher levels of t-tau and tau phosphorylated at threonine 181 (p-tau181) in their CSF compared to both PSP patients and healthy controls [30]. Here, MAPT is linked to Alzheimer disease.